Health Sciences

School of Public Health

Dr Ken Harvey

Contact Details

Email: ken.harvey@latrobe.edu.au
Mobile: 0419 181 910
Phone: (03) 9029 0634
International: +61 3 9029 0634
Fax: (03) 9818 1875
International: +61 3 9818 1875
Office: Adjunct position (home office)

Qualifications

Interests

Medicinal Drug Policy in Australia, SE Asia and elsewhere:

• Quality of drugs
• Equity of access
• Viable pharmaceutical industry
• Quality of use (especially antibiotics)

Medical Informatics:

• E-Health policy
• Electronic health records
• Decision support systems, especially prescribing and pathology

Further information

See: http://www.medreach.com.au

Publications

Harvey KJ. Does CM regulation need reform? J Comp Med 2008; 7 (3): 37.

Harvey KJ, Korczak VS, Marron LJ, Newgreen DB. Commercialism, choice and consumer protection: regulation of complementary medicines in Australia.
MJA 2008; 188 (1): 21-25.

Harvey KJ, Harris AH, Bulfone L. The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture? MJA 2007; 187 (4): 206-207.

Harvey K. Changes in Pharmaceutical Policy over the last 20 Years.
Health Issues 2006; 89: 32-38.

Faunce TA, Lofgren H, Harvey K, Johnston K. Tendering for Low Cost Generics in Australia. Health Issues, 2006; Number 87: 26-29.

Harvey K. Pharmaceutical Advertisements in Prescribing Software: What Should be Done? Health Issues, 2006; 87: 11-15.

Zhang Y, Harvey KJ. Rational antibiotic use in China: lessons learnt through introducing surgeons to Australian guidelines. Australia and New Zealand Health Policy 2006, 3 :5-17. Available: http://www.anzhealthpolicy.com/content/pdf/1743-8462-3-5.pdf

Medicare Australia Consultancy. An Economic & Equity Impact Review of National Pharmaceutical System Models. Pharmaceutical Reform Working Group Steering Committee, 2006.

Bader, R., & Harvey, K. (2005). Workshop boosts rational use activities in Jordan. Essential Drug Monitor(34), 22-23.

Sripairoj, Araya, and Ken Harvey. 2005. Ways to strengthen Drug and Therapeutics Committees (DTCs) in Thai hospitals. Essential Drug Monitor (EDM), World Health Organization 34.

Harvey, Ken J. 2005. The pharmaceutical benefits scheme 2003-2004. Australia and New Zealand Health Policy 2 (2): http://www.anzhealthpolicy.com/content/2/1/2/.

Harvey, Ken, Agnes I. Vitry, Elizabeth Roughhead, Rosalie Aroni, Nicola Ballenden, and Ralph Faggotter. 2005. Pharmaceutical advertisements in prescribing software: An analysis. Medical Journal of Australia. http://www.mja.com.au/public/issues/183_02_180705/har10263_fm.html

Lewis B, Harvey K, Dartnell J, Shepheard J. Modelling and encoding Therapeutic Guidelines: applying ICD-10-AM and European Article Number codes. Health Information Management 2004; 32: 51-58.

Harvey KJ, Faunce FA, Lokuge , Drahos P. Will the Australia–United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme? MJA 2004; 181: 256-259. Available: http://www.mja.com.au/public/rop/ausfta/har10408_fm.html

Harvey K, Kalanj K and Stevanovi R. Croatian Pharmaceutical Sector Reform Project: Rational Drug Use. CMJ 2004; 45: 611-619. Available at: http://www.cmj.hr/2004/4505/19_HARVEY.pdf

Harvey K. Patents, pills and politics: the Australia–United States Free Trade Agreement and the Pharmaceutical Benefits Scheme. Aust Health Rev 2004; 28 (2): 218-226.

Harvey K. Guidelines for Assessing Future Projects under the Quality Use of Pathology (QUP) Program. Commonwealth Department of Health & Aging, 2004.

Harvey K. Deliverable 5: Methodology for the Development of Standard Treatment Guidelines. Jordan Health Sector Reform Project, Jordan Food & Drug Administration & Australian Health Insurance Commission, 2004.

Harvey K. Deliverable 9: Study of Prescribing Practices. Jordan Health Sector Reform Project, Jordan Food & Drug Administration & Australian Health Insurance Commission, 2004.

Harvey K, McCauley V, MacIsaac P, Lewis B. Refinement of the HL7 Australia EDS Work plan: A report for the Australian Health Information Council Electronic Decision Support Steering Committee. HL7 Australia 2004.

Harvey K. Critical assessment of Jordan’s RDU & EDL within the International context. , PHRplus, Amman, Jordan, August 2005.

Aroni R, de Boer R, Harvey K. The Viagra Affair. In Evidence-based Health Policy, Edited by Lin V & Gibson B. Oxford University Press, Melbourne 2003, 97-109.

Harvey K, Dartnell J, Hemming M. Improving antibiotic use: 25 years of antibiotic guidelines and related initiatives. Commun Dis Intell 2003; 27 Suppl: S9–S11. Available: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/cda-pubs-cdi-2003-cdi27suppl-htm-cdi27supd.htm

Harvey Ken. Australian e-Health Policy: Once was Rational? Health Issues 2001: 67; 11-14.
Roughead EE, Monteith GR, Harvey KJ and Tett SE. Evaluating Australia's National Medicines Policy using Geographical Mapping. Internal Medicine Journal. 2002: 3; 66-72.

Harvey Ken. The Pharmaceutical Benefits Scheme Under Threat. Health Issues 2002: 71; 11-16.
Phanouvong S, Barraclough S, Harvey K. Improving primary health care in Thailand: The role of the National Medicinal Drug Policy. Aust J Primary Health 2002: 8; 24-30.

Harvey K. Medication management 2000: e-Scripts, e-Promotion. e-Health? Health Issues 2000; 63: 10-14.

Nolan AM, Norquay CA, Dartnell JGA, Harvey KJ. Electronic prescribing and computer-assisted decision support systems. MJA 1999; 171: 541-543.

Roughead EE, Gilbert AL, Primrose JG, Harvey KJ, Sansom LN, Report of the national indicators: Evaluating the quality use of medicines component of Australia's National Medicines Policy. Publications Production Unit, Commonwealth Department of Health and Aged Care, Canberra, 1999.

Roughead EE, Harvey KJ, Gilbert AL. Commercial detailing techniques used by pharmaceutical representatives to influence prescribing. Aust NZ J Med 1998; 28: 306-310.

Harvey KJ (Chairman), Beavis M, Christiansen K, Collignon P, Currie B, Dartnell J, Ferguson J, Harkness J, Isaacs D, Khariwala B, Kucers A, Looke D, Spicer WJ, Tosolini FA, Turnidge J. Antibiotic Guidelines 10th Ed. Therapeutic Guidelines Ltd., Melbourne 1998 (and Ed 1-6).

Roughead EE, Gilbert AL, Harvey KJ. Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners? Int J Health Serv 1998; 28: 269-279.

Harvey KJ. Drug Promotion, in Drugs in the Health Marketplace. Komesaroff PA, Wiltshire J. (Ed) Arena Publications, Melbourne 1997, 47-70.

PHARM Evaluation Sub-committee (Gilbert A, Brooks C, Corti B, Harvey K, Harvey R, James M, Murray M, Primrose J, Swift D.) Manual of Indicators to measure the effect of initiatives under the Quality Use of Medicine arm of the National Medicinal Drug Policy. Australian Government Publishing Service, Canberra 1995.

Harvey K, Murray M. Medicinal drug policy, in The Politics of Health, 2nd Ed., Gardner H (Ed) Churchill Livingstone, Melbourne, 1995, 238-283.